Prudentia Sciences is a platform enables AI-powered Asset Diligence and Valuation to De-Risk Investment in Drug Development.
Prudentia Sciences has raised $20.0M in total funding. The most recent round was Series A. The last funding was announced in January 2026.
Prudentia Sciences's investors include Virtue, SignalFire, Google Ventures, McKesson Ventures, Iaso Ventures.
Prudentia Sciences is headquartered in Cambridge, United States.
Prudentia Sciences is a platform enables AI-powered Asset Diligence and Valuation to De-Risk Investment in Drug Development.
Prudentia Sciences is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Prudentia Sciences — Funding & Investors." VCBacked, January 7, 2026, https://www.vcbacked.co/company/prudentia-sciences. Accessed July 19, 2026.
VCBacked. (2026). Prudentia Sciences — Funding & Investors. Retrieved July 19, 2026, from https://www.vcbacked.co/company/prudentia-sciences
{{cite web |title=Prudentia Sciences — Funding & Investors |url=https://www.vcbacked.co/company/prudentia-sciences |website=VCBacked |access-date=July 19, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated